A continuous analysis of albumin was used in only 15% of studies (2 of 13) evaluating complication outcomes, both of which were able to correlate albumin level with decreased risk of complications such as venous thromboembolism, pulmonary embolism, infection, and others (Paulino et al., 2019; Pennington et al., 2021b). Here, ALB is linked to venous thromboembolism.